[Clinical management of patients with depression and cardiac disease].
Depression occurs in 15 % to 20 % of patients with acute coronary syndromes and it is also and independent risk factor for morbidity and mortality. Treatment with selective serotonin reuptake inhibitors is effective, safe and may improve survival after myocardial infarction in patients with depression.
Camprubli
Marcelo
M
Guy's Hospital, Londres, Reino Unido. mecamprubi@yahoo.co.uk
Suffriti
Marcos
M
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy* / Q000453:epidemiology*; D000068736:Duloxetine Hydrochloride; D006331:Heart Diseases / Q000453:epidemiology*; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D013876:Thiophenes / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D013876:Thiophenes; D008803:Mianserin; D000068736:Duloxetine Hydrochloride; D000078785:Mirtazapine